Literature DB >> 20706769

Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese.

Bangqiong Wang1, Qifu Li, Yuanjuan Jiang, Zhoujun Liu, Li Zhong, Rong Luo, Qingfeng Cheng, Hua Qing.   

Abstract

OBJECTIVE: To compare association of complement C3 (C3) and high sensitive C-reactive protein (hs-CRP) with insulin resistance.
SUBJECTS: A total of 587 non-diabetic Chinese aged 20-80 years were recruited.
METHODS: Complement C3 and hs-CRP were measured by the rate nephelometry method and the particle enhanced immunoturbidimetric method, respectively, and their relationship to insulin resistance was assessed. Insulin resistance was defined as the upper quartile of HOMA2-IR.
RESULTS: Complement C3 and hs-CRP were significantly higher in subjects with insulin resistance than those without. Complement C3 was the second strongest determinant of insulin in the study (β = 0.34, P < 0.001). By regression analysis, C3 was significantly associated with insulin resistance (OR = 3.78, P < 0.05), independent of waist circumference and other metabolic risk factors; however, hs-CRP was not. Receiver operating characteristic curve analysis indicated the best model predicting insulin resistance was one that included C3 and waist circumference (AUC = 0.741, P < 0.05).
CONCLUSION: Compared to hs-CRP, serum C3 might be a better inflammatory marker of insulin resistance in the non-diabetic Chinese population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20706769     DOI: 10.1007/s00011-010-0236-y

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  25 in total

1.  Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin.

Authors:  C J Halkes; H van Dijk; P P de Jaegere; H W Plokker; Y van Der Helm; D W Erkelens; M Castro Cabezas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

2.  Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia.

Authors:  S Meijssen; H van Dijk; C Verseyden; D W Erkelens; M Castro Cabezas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

3.  Additive effect of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis.

Authors:  S Mantov; D Raev
Journal:  Int J Cardiol       Date:  1996-10-11       Impact factor: 4.164

4.  Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study.

Authors:  M Pyörälä; H Miettinen; P Halonen; M Laakso; K Pyörälä
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

5.  Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.

Authors:  Gunnar Engström; Bo Hedblad; Karl-Fredrik Eriksson; Lars Janzon; Folke Lindgärde
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

6.  Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study.

Authors:  J S Yudkin; I Juhan-Vague; E Hawe; S E Humphries; G di Minno; M Margaglione; E Tremoli; T Kooistra; P E Morange; P Lundman; V Mohamed-Ali; A Hamsten
Journal:  Metabolism       Date:  2004-07       Impact factor: 8.694

7.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

Authors:  P M Ridker; R J Glynn; C H Hennekens
Journal:  Circulation       Date:  1998-05-26       Impact factor: 29.690

8.  Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men.

Authors:  Tobias Pischon; Frank B Hu; Kathryn M Rexrode; Cynthia J Girman; Joann E Manson; Eric B Rimm
Journal:  Atherosclerosis       Date:  2007-08-02       Impact factor: 5.162

9.  Complement C3 and C-reactive protein in male survivors of myocardial infarction.

Authors:  Angela M Carter; Usha K Prasad; Peter J Grant
Journal:  Atherosclerosis       Date:  2008-07-19       Impact factor: 5.162

View more
  6 in total

1.  Interleukin-6 is a better metabolic biomarker than interleukin-18 in young healthy adults.

Authors:  Júlia Cristina Cardoso Carraro; Helen Hermana M Hermsdorff; Blanca Puchau; M Ángeles Zulet; Fermín I Milagro; Josefina Bressan; J Alfredo Martínez
Journal:  J Physiol Biochem       Date:  2015-02-27       Impact factor: 4.158

2.  Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients.

Authors:  Francesco Ursini; Alessandro Grembiale; Saverio Naty; Rosa Daniela Grembiale
Journal:  Clin Rheumatol       Date:  2013-09-05       Impact factor: 2.980

3.  Contribution of gender and body fat distribution to inflammatory marker concentrations in apparently healthy young adults.

Authors:  Helen Hermana M Hermsdorff; Ana Carolina P Volp; Blanca Puchau; Kiriaque B F Barbosa; M Angeles Zulet; Josefina Bressan; J Alfredo Martínez
Journal:  Inflamm Res       Date:  2012-01-19       Impact factor: 4.575

4.  Maternal serum proteomic profiles of pregnant women with type 1 diabetes.

Authors:  Marzena Gajecka; Ewa Wender-Ozegowska; Paweł Gutaj; Jan Matysiak; Eliza Matuszewska; Katarzyna Jaskiewicz; Dorota Kamińska; Agata Światły-Błaszkiewicz; Tomasz Szczapa; Anastasia Kalantarova
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

Review 5.  Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis.

Authors:  Rosario Peluso; Francesco Caso; Marco Tasso; Vincenzo Sabbatino; Roberta Lupoli; Matteo Nicola Dario Di Minno; Francesco Ursini; Luisa Costa; Raffaele Scarpa
Journal:  Open Access Rheumatol       Date:  2019-06-28

6.  MALDI-TOF MS Characterisation of the Serum Proteomic Profile in Insulin-Resistant Normal-Weight Individuals.

Authors:  Katarzyna Pastusiak; Eliza Matuszewska; Dagmara Pietkiewicz; Jan Matysiak; Pawel Bogdanski
Journal:  Nutrients       Date:  2021-10-28       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.